APRIL PALMER: Open Payments
NPI 1184130056 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,535 in 112 payments from 19 companies in 2025. Trend: 2023 $690 · 2024 $1,285 · 2025 $2,535
Food & beverage: $2,450Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $527 |
| Madrigal Pharmaceuticals | 7 | $407 |
| ABBVIE INC. | 24 | $308 |
| GENZYME CORPORATION | 6 | $221 |
| Ardelyx, Inc. | 8 | $180 |
| PFIZER INC. | 15 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $141 |
| Regeneron Healthcare Solutions, Inc. | 6 | $116 |
| Intercept Pharmaceuticals, Inc. | 4 | $85 |
| Lilly USA, LLC | 4 | $78 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, IBSRELA, CREON, ENTYVIO, XELJANZ, OCALIVA.
Industry payments across PA — which companies pay providers there.
